Table 3:
In All Patients | AIC | G2 | P Value |
---|---|---|---|
CBF-GM-Rel | |||
Null model | 291.5 | – | |
A) Without any covariate | 291.7 | 1.796 | .1803 |
B) With covariates | 291.3 | 2.247 | .1338 |
CBF-WM-Rel | |||
Null model | 282.5 | – | |
A) Without any covariate | 280.4 | 4.080 | .0434 |
B) With covariates | 268.9 | 15.613 | <.0001b |
Tmax-GM-Abs | |||
Null model | 291.5 | – | |
A) Without any covariate | 291.3 | 2.255 | .1332 |
B) With covariates | 285.4 | 8.116 | .0044b |
Tmax-WM-Abs | |||
Null model | 282.5 | – | |
A) Without any covariate | 280.9 | 3.643 | .0563 |
B) With covariates | 266.2 | 18.328 | <.0001b |
Note:—Rel indicates relative to the contralateral side; Abs, absolute value; AIC, Akaike Information Criterion; G2, the difference between −2 L of the fitted model (transformed threshold) and the reference model (nontransformed threshold).
Remaining parameters are presented in On-line Table 3.
Significant.